Improving drug safety and effectiveness through genetic testing.
Clinical Implementation Resources for Pharmacogenomics (CIRP)
This study is all about using your genes to help doctors choose the best medications for you, so you get the most benefit and the least side effects, making your treatment safer and more effective.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10925243 on NIH RePORTER |
What this research studies
This research focuses on enhancing precision medicine by understanding how genetic variations affect individual responses to medications. It aims to implement pharmacogenomics, which involves using genetic tests to guide drug prescriptions, thereby maximizing treatment efficacy and minimizing adverse effects. The project will develop resources and tools to help healthcare providers interpret genetic data and make informed prescribing decisions. By addressing the significant issue of adverse drug reactions, this initiative seeks to improve patient outcomes and reduce healthcare costs.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are prescribed medications that may be influenced by genetic factors.
Not a fit: Patients who are not taking medications or whose drug responses are not affected by genetic variations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of adverse drug reactions and improve the effectiveness of medications for patients.
How similar studies have performed: Previous research has shown success in implementing pharmacogenomics in clinical settings, indicating a promising approach for improving patient care.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Klein, Teri Ellen — Stanford University
- Study coordinator: Klein, Teri Ellen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.